CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Kissei Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Kissei Pharmaceutical Co Ltd
19-48, Yoshino
Phone: +81 263259081p:+81 263259081 MATSUMOTO-SHI, NGN  399-8710  Japan Ticker: 45474547
Business Summary
Kissei Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the pharmaceutical business. The Company operates through four segments. The Pharmaceutical segment manufactures and sells prescription drugs, and also purchases and sells healthcare foods such as prescription drugs and foods for special medical purposes. The Goods Sales segment is engaged in the development, production and sale of noodles, the sale of various equipment, vehicles and fuel, as well as insurance agency business. The Information Services segment operates in three areas including system integration services, system resource services such as information-related equipment rental and network construction, and medical system development and sales. The Construction and Facility Maintenance segment provides comprehensive construction services ranging from building construction to the maintenance and management of equipment and facilities.
(Source: ARS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20253/31/2025Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
7373 Computer integrated systems design
7374 Computer processing and data preparation and processing services
1541 General contractors-industrial buildings and warehouses
1542 General contractors-nonresidential buildings, other than industrial
6531 Real estate agents and managers
2098 Macaroni, spaghetti, vermicelli, and noodles
6411 Insurance agents, brokers, and service

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Executive Officer, Representative Director MutsuoKanzawa 75 6/27/2014 6/1/1982
President, Chief Operating Officer, Representative Director YasuoTakehana 64 6/1/2022 6/1/2012
Chief Financial Officer, Managing Director, Director of Finance and Administration TakahideKitahara 63 10/1/2023 6/1/2018
12 additional Officers and Directors records available in full report.

Business Names
Business Name
4547
Kissei Pharmaceutical Co., Ltd.

General Information
Number of Employees: 1,778 (As of 3/31/2025)
Outstanding Shares: 41,452,593 (As of 9/30/2025)
Shareholders: 3,366
Stock Exchange: TYO
Fax Number: +81 263257899


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, December 7, 2025